Sign up to save your podcasts
Or
Share Day 3: Top Takeaways From ASCO26
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Day 3: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma.
LINK TO FULL TRANSCRIPT
View all episodes
By American Society of Clinical Oncology (ASCO)
4.6
5656 ratings
Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma.
LINK TO FULL TRANSCRIPT
More shows like ASCO Daily News
View all
NEJM This Week
317 Listeners
JAMA Clinical Reviews
505 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Breast Cancer Update
67 Listeners
Nature Podcast
768 Listeners
Research To Practice | Oncology Videos
121 Listeners
All Ears English Podcast
2,241 Listeners
Science Magazine Podcast
821 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
46 Listeners
ASCO Education
31 Listeners
Think Fast Talk Smart: Communication Techniques
844 Listeners
Oncology Today with Dr Neil Love
59 Listeners
Two Onc Docs
196 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
47 Listeners